---
title: The Business Case for Investing in Genomics
description: Learn more from James Lu, MD, PhD in a panel discussion with the Academy about the business case for investing in genomics.
---

[![Helix](https://info.helix.com/hubfs/raw_assets/public/Helix_February2022/images/logo-helix.png "Helix")](https://www.helix.com/)

![Academy Business Case Banner (1)](https://info.helix.com/hubfs/Academy%20Business%20Case%20Banner%20(1).png "Academy Business Case Banner (1)")

Advancements in technology and DNA sequencing are making precision medicine more accessible and affordable driving increasing interest from providers and consumers. The promise of more data-driven care and early detection can help health systems advance strategic goals like reducing the cost of care and attracting consumers. While some early adopters have seen ROI, there remains uncertainty about how best to scale these programs and create a business line to support the necessary investment, particularly in these difficult economic times.

During this panel discussion hosted by The Academy several industry partners in the precision medicine and genomics space will discuss how to build a genomics program to attract consumers and generate additional revenue for the system.

 

Panelists include:

- Haibo Lu, Co-Founder and Chief Product Officer, Cancer IQ
- Lisa Alderson, CEO & Co-founder, Genome Medical
- Dr. James Lu, CEO & Co-founder, Helix
- Dr. Phil Febbo, CMO, Illumina

# Watch webinar on-demand

Access the recording

[![Helix](https://info.helix.com/hs-fs/hubfs/raw_assets/public/Helix_February2022/images/logo-helix.png?width=200&name=logo-helix.png "Helix")](https://www.helix.com/)

Empowering every person to improve their life through DNA.

(844) 211-2070  |  Monday–Friday, 7am–4pm Pacific

© 2026 Helix, Inc. All rights reserved.

Helix, the Helix logo, Exome+, and Sequence Once, Query Often are trademarks of Helix, Inc.

- [Privacy Policy](https://www.helix.com/pages/privacy-policy)
- [Terms of Service](https://www.helix.com/pages/terms-of-service)
- [Notice of Privacy Practices](https://www.helix.com/pages/notice-of-privacy-practices)
- [Platform Consent](https://www.helix.com/pages/platform-consent)
- [Research Consent](https://www.helix.com/research-consent)
- [Your Privacy Choices](https://www.helix.com/privacy-preference-center.html)

CLIA #05D2117342  CAP #9382893